🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: \- to evaluate the efficacy of Sarilumab in participant...
Status
Completed
Location
Investigational Site Number 840006
Start Date
2010-02
Trial ID
NCT01061723
Primary Objective: To evaluate the relative risk of major structural birth...
Status
Completed
Location
United States
Start Date
2018-05-18
Trial ID
NCT03378219
Treatments Being Tested
Primary Objective: To evaluate the clinical efficacy of sarilumab relative...
Status
Completed
Location
Investigational Site Number 0320001
Start Date
2020-03-28
Trial ID
NCT04327388
Treatments Being Tested
Primary Objective: To evaluate the effect of a single 200 mg subcutaneous ...
Status
Completed
Location
Investigational Site Number 840002
Start Date
2014-01
Trial ID
NCT02017639
Treatments Being Tested
Primary Objective: To describe the safety and tolerability, including labo...
Status
Completed
Location
Investigational Site Number 392001
Start Date
2015-05
Trial ID
NCT02404558
Treatments Being Tested
This study will test the safety and tolerability (how the body reacts to th...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT01055899
Primary Objective: To evaluate the efficacy of KEVZARA (sarilumab) in part...
Status
Terminated
Location
Investigational Site Number 8400003
Start Date
2018-10-09
Trial ID
NCT03600818
Primary Objective: To describe the pharmacokinetic (PK) profile of sarilum...
Status
Completed
Location
Children's Hospital Los Angeles Site Number : 8400416
Start Date
2016-09-06
Trial ID
NCT02776735
Treatments Being Tested
Primary Objective: To assess the effect of sarilumab in combination with c...
Status
Completed
Location
Investigational Site Number 250007
Start Date
2018-03-05
Trial ID
NCT03449758
Treatments Being Tested
Primary Objective: -To demonstrate that sarilumab added to methotrexate (M...
Status
Completed
Location
Investigational Site Number 392010
Start Date
2014-11
Trial ID
NCT02293902
Treatments Being Tested